Corient Private Wealth LLC lowered its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 25.1% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 43,140 shares of the exchange traded fund’s stock after selling 14,439 shares during the period. Corient Private Wealth LLC owned approximately 0.08% of SPDR S&P Biotech ETF worth $3,578,000 as of its most recent SEC filing.
Several other large investors also recently added to or reduced their stakes in the stock. Capital A Wealth Management LLC bought a new stake in shares of SPDR S&P Biotech ETF in the 2nd quarter valued at approximately $26,000. DHJJ Financial Advisors Ltd. bought a new stake in SPDR S&P Biotech ETF in the second quarter worth $25,000. Twin Peaks Wealth Advisors LLC bought a new stake in SPDR S&P Biotech ETF in the second quarter worth $32,000. Johnson Financial Group Inc. purchased a new position in SPDR S&P Biotech ETF during the second quarter worth $31,000. Finally, AlphaCore Capital LLC increased its position in SPDR S&P Biotech ETF by 6,650.0% during the second quarter. AlphaCore Capital LLC now owns 540 shares of the exchange traded fund’s stock valued at $45,000 after acquiring an additional 532 shares during the last quarter.
SPDR S&P Biotech ETF Trading Up 2.8%
Shares of XBI opened at $123.43 on Monday. The company’s fifty day simple moving average is $115.20 and its 200-day simple moving average is $98.82. The company has a market cap of $7.49 billion, a P/E ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a twelve month low of $66.66 and a twelve month high of $125.87.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Featured Articles
- Five stocks we like better than SPDR S&P Biotech ETF
- I Shouldn’t Be Sending You This
- REVEALED: America just unlocked a $500 trillion asset
- Wall Street Stock picker Names #1 Stock of 2026
- They Laughed at $30. They Won’t Laugh at $70.
- How Long Will $1M Last in Retirement?
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
